Mark D. Rosen

774 total citations
16 papers, 600 citations indexed

About

Mark D. Rosen is a scholar working on Molecular Biology, Organic Chemistry and Cell Biology. According to data from OpenAlex, Mark D. Rosen has authored 16 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Cell Biology. Recurrent topics in Mark D. Rosen's work include Cancer, Hypoxia, and Metabolism (5 papers), Endoplasmic Reticulum Stress and Disease (4 papers) and Synthetic Organic Chemistry Methods (4 papers). Mark D. Rosen is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Endoplasmic Reticulum Stress and Disease (4 papers) and Synthetic Organic Chemistry Methods (4 papers). Mark D. Rosen collaborates with scholars based in United States, Belgium and Spain. Mark D. Rosen's co-authors include Larry E. Overman, Michael H. Rabinowitz, Jeremy P. Scott, Terrance D. Barrett, Lothar Schwink, Nigel P. Shankley, Kimon C. Kanelakis, Wen Yan, Hariharan Venkatesan and Xiaodong Wu and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Infection and Immunity.

In The Last Decade

Mark D. Rosen

16 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark D. Rosen United States 11 321 181 115 57 50 16 600
Wen‐Zhen Gu United States 14 221 0.7× 360 2.0× 51 0.4× 30 0.5× 33 0.7× 26 686
Fuchun Xie China 17 456 1.4× 321 1.8× 53 0.5× 30 0.5× 30 0.6× 32 950
Takayuki Okuno Japan 14 260 0.8× 272 1.5× 49 0.4× 42 0.7× 6 0.1× 29 688
Marina W. H. Shen United States 11 125 0.4× 271 1.5× 61 0.5× 19 0.3× 9 0.2× 14 512
Raymond J. Patch United States 16 396 1.2× 448 2.5× 36 0.3× 17 0.3× 25 0.5× 30 902
Jennifer L. Olkowski United States 10 133 0.4× 362 2.0× 43 0.4× 48 0.8× 33 0.7× 16 589
Dominick Mobilio United States 9 132 0.4× 278 1.5× 85 0.7× 25 0.4× 14 0.3× 13 544
Nigel G. Cooke Switzerland 12 304 0.9× 550 3.0× 14 0.1× 60 1.1× 28 0.6× 17 877
Noriko Uchiyama Japan 14 183 0.6× 477 2.6× 38 0.3× 74 1.3× 34 0.7× 28 769
Michael Mortimore United States 12 361 1.1× 432 2.4× 51 0.4× 131 2.3× 15 0.3× 13 883

Countries citing papers authored by Mark D. Rosen

Since Specialization
Citations

This map shows the geographic impact of Mark D. Rosen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Rosen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Rosen more than expected).

Fields of papers citing papers by Mark D. Rosen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Rosen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Rosen. The network helps show where Mark D. Rosen may publish in the future.

Co-authorship network of co-authors of Mark D. Rosen

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. Rosen. A scholar is included among the top collaborators of Mark D. Rosen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. Rosen. Mark D. Rosen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bembenek, Scott D., Hariharan Venkatesan, Hillary M. Peltier, et al.. (2019). Beyond Traditional Structure-Based Drug Design: The Role of Iron Complexation, Strain, and Water in the Binding of Inhibitors for Hypoxia-Inducible Factor Prolyl Hydroxylase 2. ACS Omega. 4(4). 6703–6708. 6 indexed citations
2.
Boucher, Justin C., Niraj Shrestha, Mark D. Rosen, et al.. (2018). The eIF2α Kinase Heme-Regulated Inhibitor Protects the Host from Infection by Regulating Intracellular Pathogen Trafficking. Infection and Immunity. 86(3). 10 indexed citations
3.
ILL‐Raga, Gerard, Marta Tajes, Arnau Busquets-García, et al.. (2015). Physiological Control of Nitric Oxide in Neuronal BACE1 Translation by Heme-Regulated eIF2α Kinase HRI Induces Synaptogenesis. Antioxidants and Redox Signaling. 22(15). 1295–1307. 27 indexed citations
4.
Barrett, Terrance D., Kimon C. Kanelakis, Xiaodong Wu, et al.. (2015). Prolyl hydroxylase inhibition corrects functional iron deficiency and inflammation‐induced anaemia in rats. British Journal of Pharmacology. 172(16). 4078–4088. 42 indexed citations
5.
ILL‐Raga, Gerard, Cristiano A. Köhler, Andressa Radiske, et al.. (2013). Consolidation of object recognition memory requires HRI kinase‐dependent phosphorylation of eIF2α in the hippocampus. Hippocampus. 23(6). 431–436. 26 indexed citations
6.
7.
8.
Rosen, Mark D., Hariharan Venkatesan, Hillary M. Peltier, et al.. (2010). Benzimidazole-2-pyrazole HIF Prolyl 4-Hydroxylase Inhibitors as Oral Erythropoietin Secretagogues. ACS Medicinal Chemistry Letters. 1(9). 526–529. 55 indexed citations
9.
Rosen, Mark D., Craig R. Woods, Steven D. Goldberg, et al.. (2009). Discovery of the first known small-molecule inhibitors of heme-regulated eukaryotic initiation factor 2α (HRI) kinase. Bioorganic & Medicinal Chemistry Letters. 19(23). 6548–6551. 34 indexed citations
10.
Kanelakis, Kimon C., Lina Li, Jiejun Wu, et al.. (2009). Characterization of a Robust Enzymatic Assay for Inhibitors of 2-Oxoglutarate-Dependent Hydroxylases. SLAS DISCOVERY. 14(6). 627–635. 13 indexed citations
11.
Rosen, Mark D., et al.. (2009). A general method for the synthesis of benzimidazole-4-sulfonamides. Tetrahedron Letters. 50(11). 1219–1221. 8 indexed citations
12.
Rosen, Mark D., Michael D. Hack, Brett D. Allison, et al.. (2008). Discovery of potent cholecystokinin-2 receptor antagonists: Elucidation of key pharmacophore elements by X-ray crystallographic and NMR conformational analysis. Bioorganic & Medicinal Chemistry. 16(7). 3917–3925. 7 indexed citations
13.
Woods, Craig R., Michael D. Hack, Brett D. Allison, et al.. (2007). Synthesis and solid-phase purification of anthranilic sulfonamides as CCK-2 ligands. Bioorganic & Medicinal Chemistry Letters. 17(24). 6905–6909. 8 indexed citations
14.
Overman, Larry E., et al.. (2003). Total Synthesis of (±)-Didehydrostemofoline (Asparagamine A) and (±)-Isodidehydrostemofoline. Journal of the American Chemical Society. 125(50). 15284–15285. 81 indexed citations
15.
Overman, Larry E. & Mark D. Rosen. (2000). Total Synthesis of (−)-Spirotryprostatin B and Three Stereoisomers. Angewandte Chemie International Edition. 39(24). 4596–4599. 143 indexed citations
16.
Overman, Larry E. & Mark D. Rosen. (2000). Totalsynthese von (−)-Spirotryprostatin B und drei Stereoisomeren. Angewandte Chemie. 112(24). 4768–4771. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wen‐Zhen Gu Breakdown of academic impact, for papers by Fuchun Xie Breakdown of academic impact, for papers by Takayuki Okuno Breakdown of academic impact, for papers by Marina W. H. Shen Breakdown of academic impact, for papers by Raymond J. Patch Breakdown of academic impact, for papers by Jennifer L. Olkowski Breakdown of academic impact, for papers by Dominick Mobilio Breakdown of academic impact, for papers by Nigel G. Cooke Breakdown of academic impact, for papers by Noriko Uchiyama Breakdown of academic impact, for papers by Michael Mortimore
Rankless by CCL
2026